1st ed. 2019 Edition
by Gabriel G. Malouf (Editor), Nizar M. Tannir (Editor)
This book provides clinicians with clear guidance on treatment
decision-making in patients with rare kidney cancers. After a brief
review on epidemiology, pathology, and biology, each chapter focuses on
the multidisciplinary management of a particular tumor subtype using the
full range of available cancer therapy modalities, including surgery,
radiotherapy, chemotherapy, targeted therapies, and immunotherapy.
Emerging therapies and future directions in the management of each
cancer subtype are also discussed. The chapters are all written by
multidisciplinary teams of international experts comprising at least a
urologist, a medical oncologist, and a pathologist.
Rare kidney
cancers represent 15% of renal cell carcinomas. In comparison with clear
cell renal cell carcinomas, little is known about the biology of such
cancers, and few trials have reported on the efficacy of targeted
therapies in the metastatic setting. Optimal management thus poses
significant challenges and often requires a multidisciplinary team. This
book will be an ideal reference guide for all clinicians involved in
the care of patients with these orphan tumors.
